• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE? HF ICD DR; Implantable Cardioverter Defibrillator (ICD)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE? HF ICD DR; Implantable Cardioverter Defibrillator (ICD) Back to Search Results
Model Number D533
Medical Device Problem Codes Failure to Convert Rhythm (1540); Inappropriate/Inadequate Shock/Stimulation (1574)
Health Effect - Clinical Code Shock from Patient Lead(s) (3162)
Date of Event 06/30/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient with this implantable cardioverter defibrillator (icd) experienced ventricular tachycardia (vt) for which the implanted defibrillator delivered six appropriate shocks; however, the arrhythmia was not terminated by device therapy.The patient reported that intravenous amiodarone was subsequently administered, resulting in successful conversion of the arrhythmia.Additional information indicated that post-event defibrillation threshold (dft) testing demonstrated successful conversion with the first shock.The patient contacted technical services (ts) to inquire why the delivered therapies were unsuccessful and was advised that multiple factors may influence therapy efficacy.The patient was referred for further evaluation.No additional adverse patient effects were reported.This icd remains in service.
 
Event or Problem Description
It was reported that the patient with this implantable cardioverter defibrillator (icd) experienced ventricular tachycardia (vt) for which the implanted defibrillator delivered six appropriate shocks; however, the arrhythmia was not terminated by device therapy.The patient reported that intravenous amiodarone was subsequently administered, resulting in successful conversion of the arrhythmia.Additional information indicated that post-event defibrillation threshold (dft) testing demonstrated successful conversion with the first shock.The patient contacted technical services (ts) to inquire why the delivered therapies were unsuccessful and was advised that multiple factors may influence therapy efficacy.The patient was referred for further evaluation.No additional adverse patient effects were reported.This icd remains in service.
 
Additional Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of difficulty converting rhythm (ambulatory) was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code cause not established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE? HF ICD DR
Common Device Name
Implantable Cardioverter Defibrillator (ICD)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
Boston Scientific Corporation
cashel road
clonmel E91 T 862
EI   E91 T862
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
+1(651)582-6168
MDR Report Key50244666
Report Number2124215-2026-43575
Device Sequence Number10378437
Product Code LWS
UDI-Device Identifier00802526588310
UDI-Public(01)00802526588310(17)260812
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P960040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 08/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date08/12/2026
Device Model NumberD533
Device Catalogue NumberD533
Device Lot Number682683
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/24/2026
Initial Report FDA Received Date08/13/2026
Date Device Manufactured08/29/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age76 YR
Patient SexMale
-
-